Back to Top

"One of today's leaders in investor relations and shareholder services"

Tag Archives: Cannabis

MJNA Numbers Don’t Lie This is a Company on the Rise

Medical Marijuana, Inc. has earned its title as a leader in the medical marijuana industry. It’s pioneering the way for more acceptance of medicinal marijuana as well as deriving revolutionary products. Today, the company is yet again proving itself and standing stronger than ever with record sales for a month.

Who is Medical Marijuana, Inc.?

Medical Marijuana, Inc, is a premier hemp and cannabis industry leader. With innovative ideas from experts in the field, the company is continuing to develop unique products that benefit overall health and wellness. The company focuses on creating awareness about the cannabis industry. The company develops environmentally-friendly and sustainable products. Additionally, Medical Marijuana, Inc. increases shareholder value with each and every product they develop.

Medical Marijuana, Inc. touts about being a company of firsts. It’s the first publicly traded cannabis company ever in the United States. Moreover, it’s the first direct sales and network …

Continue Reading

Posted in Articles| Tagged , , , , |

Medical Marijuana, Inc. Portfolio company KannaLife Sciences, Wraps Up Media Tour Discussing CTE in New York with New Spokesman, Nick Lowery

Former Kansas City Chiefs Placekicker spoke with Fox Business, CBS Sports, NBC and i24 News.

SAN DIEGO, Sept. 29, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, today announced that portfolio company KannaLife Sciences‘ new spokesman Nick Lowery and former Kansas City Chiefs placekicker, generated a massive amount of media coverage across the United States about the dangers of chronic traumatic encephalopathy (CTE).

CTE is a degenerative neurological disease caused by repeated head trauma and only diagnosable with certainty in post-mortem examinations and can lead to symptoms like violent mood swings, depression and other cognitive difficulties. Because there is not much known about this debilitating disease, treatment and prevention options are bleak.

A September 26, 2017 interview with Fox Business’ Varney & Co., discussed current research on the diagnosis and treatment of CTE, and its relationship to professional sports organizations …

Continue Reading

Posted in Client News| Tagged , , , |

Terra Tech Corp. CEO, Derek Peterson, Discusses Recent News in a New Audio Interview at SmallCapVoice.com

AUSTIN, Texas, Sept. 27, 2017 (GLOBE NEWSWIRE) — SmallCapVoice.com, Inc. (SCV) and Terra Tech Corp. (OTCQX:TRTC) (“Terra Tech”) or (the “Company”), a vertically integrated cannabis-focused agriculture company, announced today that a new audio interview with the Company, is now available. The interview can be heard at http://smallcapvoice.com/blog/9-27-17-smallcapvoice-interview-with-terra-tech-corp-trtc

Derek Peterson, Chief Executive Officer of Terra Tech called in to SmallCapVoice.com to go over the news for Terra Tech Corp. Topics covered in the interview include the recent share conversion, the two new craft cultivators in California, the provisional patent application for innovative cannabis-infused rolling papers, the LOI to acquire 50% of NuLeaf Sparks Cultivation LLC and NuLeaf Reno Production LLC and much more.

“Terra Tech is currently embarking on a period of rapid expansion, marked by progress across all areas of the business,” commented Mr. Derek Peterson. “We are taking advantage of the ongoing consolidation in the California market to expand …

Continue Reading

Posted in Client News| Tagged , |

Medical Marijuana, Inc. Announces that August 2017 was the Largest Revenue Sales Month in Company History

Medical Marijuana, Inc. Wholly Owned Subsidiaries Kannaway® and HempMeds® Mexico Had the Largest Sales Month in August Since Companies Were Founded

SAN DIEGO, Sept. 11, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that August 2017 was the Company’s largest revenue month in its history. Additionally, wholly-owned subsidiaries Kannaway® and HempMeds® Mexico experienced their largest months of revenue in their respective histories. 

“Kannaway’s growth has been particularly stunning since it’s re-launch in March 2016,” said Kannaway CEO, Blake Schroeder. “Kannaway’s revenue has increased over 25 times during that time-period, and the company intends to launch a series of new products in Q4 2017 as it gears up for its regional convention this fall in Denver, Co. Additionally, there are plans to launch into Europe later this year. We fully expect Kannaway’s aggressive growth to continue!”

“As we continue to …

Continue Reading

Posted in Client News| Tagged , , , , |

Terra Tech Corp. Files Provisional Patent Application for Cannabis-Infused Rolling Papers

IRVINE, CA–(Marketwired – September 07, 2017) – Terra Tech Corp. (OTCQX: TRTC) (“Terra Tech” or the “Company”), a vertically integrated, cannabis-focused agriculture company, announced it has filed a patent application with the U.S. Patent and Trademark Office (USPTO) for innovative cannabis-infused rolling papers. The inventive rolling papers, which are expected to launch in 2018, will be the latest addition to the Company’s portfolio of IVXX™ branded premium cannabis products, which includes flowers, concentrates, custom-rolled joints and edibles. As with all IVXX products, the rolling papers will be free of toxic pesticides, harmful molds and chemical residues.

The patent application covers the infusion of cannabis concentrates in rolling papers to achieve enhanced levels of active ingredients. Rolling papers with varying concentrations of cannabis concentrate, as well as with varying flavors and aromas, can be produced to achieve a personalized experience for the user. As part of Terra Tech’s aggressive IP protection …

Continue Reading

Posted in Client News| Tagged , |

AXIM Biotech to Present at Rodman & Renshaw 19th Annual Global Investment Conference in New York City

NEW YORK, Sept. 07, 2017 (GLOBE NEWSWIRE) — AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the Company will be featured as a presenting company at the Rodman & Renshaw 19th Annual Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The conference is being held on September 11-12, 2017 at the Lotte New York Palace Hotel in New York City.

George Anastassov, MD, DDS, MBA and Chief Executive Officer of AXIM, will present a corporate update at the Conference on September 11 at 5:05-5:30pm ET in Kennedy II. AXIM’s management will also be holding one-on-one meetings with investors at the Conference.

The Global Investment Conference, which will feature more than 300 public and private companies from around the world, with over 2,000 attendees, offers investors sector tracks devoted to Biotechnology & Healthcare, Metals & Mining, CleanTech, Technology and Media …

Continue Reading

Posted in Client News| Tagged , , |